I use media and public conversations to share reactions, invite readers’ views, and engage with questions about healthcare, business, and innovation. These posts preserve what I said about the linked items and conversations; their destinations or full contents are not always available.
I wrote, “Love the title Expertise-wali 😂, good read !” about a linked item whose author and subject I did not identify.
I shared a link to “My column in @business_today, your views ?” without identifying the column’s subject or the responses readers offered.
I enjoyed my Reddit AMA and answered 40 questions in 40 minutes.
After my Reddit AMA, I said, “I’m always amused by the questions asked”. The captured post does not identify the questions or the destinations of its two links.
I wrote, “I had heard about Vikas Dandekar when I moved back to India & joined Emcure 18 years back”.
I wrote, “I met him only a year back”.
I wrote, “when he did a podcast with me, Aman Mehta of Torrent & Sharvil Patel of Zydus.”
I wrote, “I had expected to meet a very serious, grumpy, angry looking person”.
I wrote, “I was blown away by his loud laughter, warmth & joie de vivre.”
I wrote, “Since then we have met often” for deep discussions about healthcare in India.
I said I was impressed by “his choice of topics to cover, he picks topics that are often ignored & overlooked”.
I praised the depth of Vikas’s research, writing: “2) the depth of his research”.
I wrote, “his write ups on rare diseases especially spinal muscular atrophy is one of his finest works”.
I described Vikas’s reporting method with the words, “the extensive reading followed by in person meetings to fact find”.
I praised Vikas’s editorial independence, writing, “Once that pen starts rolling”.
I wrote, “I never do talks” and explained that I see no value in repeating my life story or perspectives “again & again & again”; I made an exception for Vikas, saying, “when Vikas calls, there is no way I can say no.”
I described the Economic Times talk as “A strong community of healthcare that was engaged & curious to discuss the future of innovation, the challenges & the role of women !”
I raised the question, “How will there solutions for women when meetings have no women in the research or marketing discussions ?”
I asked, “How will women join sales when the hours to meet doctors are mostly so late in the day ?”
I raised the question, “What are the challenges I’m seeing while building my consumer business ?”
I raised the question, “My perspective on innovation in Indian pharma ?”
I described Vikas’s moderation this way: “His moderation as always was tough yet warm.”
I thanked Vikas and wrote, “may you keep the torch of honest & soulful reporting alive for decades & inspire many to follow !”
Related: pharma leadership and partnerships, healthcare innovation, articles and columns